Reports have demonstrated CNTN1 to be upregulated in many types of cancer such as lung cancer, oesophageal squamous cell carcinomas, gastric cancer, thyroid cancer, prostate cancer and hepatocellular carcinoma, suggesting its contribution to carcinoma progression, invasion, and metastasis (Li et al., 2021). Here, CNTN1 is linked to hepatocellular carcinoma.